13F filer · CIK 78003
Pfizer Inc
New York, NY · filing since Q4 2024 · last filing Aug 13, 2026
Reported value
$170.4M
$-68.4M vs prior
Positions
17
New / sold out
0 / 1
Added / reduced
0 / 3
Turnover
0.0%
buys $0 · sells $55.2M
Top-10 weight
95.8%
Biggest buys vs Q1 2026
No new or increased positions this quarter.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | ORIC PHARMACEUTICALS INC | -4,407,497 | -92.2% | $-42.0M |
| Reduced | ZURA BIO LTD | -2,300,072 | -81.0% | $-12.3M |
| Sold out | Q32 BIO INC | -101,618 | -100.0% | $-736.7K |
| Reduced | NEXTCURE INC | -109,007 | -71.1% | $-179.4K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ALLOGENE THERAPEUTICS INCCOM | 22,032,040 | $46.9M | 27.55% |
| 2 | CELCUITY INCCOM | 295,652 | $29.6M | 17.35% |
| 3 | ARVINAS INCCOM | 3,457,815 | $27.7M | 16.24% |
| 4 | PYXIS ONCOLOGY INCCOMMON STOCK | 7,032,770 | $19.5M | 11.43% |
| 5 | WAVE LIFE SCIENCES LTDSHS | 1,875,000 | $10.9M | 6.42% |
| 6 | BIOHAVEN LTDCOM | 505,645 | $8.0M | 4.70% |
| 7 | CARIBOU BIOSCIENCES INCCOM | 4,690,431 | $7.9M | 4.63% |
| 8 | SPERO THERAPEUTICS INCCOM | 2,362,348 | $5.3M | 3.13% |
| 9 | ZENTALIS PHARMACEUTICALS INCCOM | 953,834 | $3.9M | 2.26% |
| 10 | ORIC PHARMACEUTICALS INCCOM | 372,904 | $3.6M | 2.09% |
7 more rows. Subscribe for $29/month to see every row, download the data and use the API.